Em Pernambuco, um surto de lesões cutâneas que afeta mais de 400 pessoas em 12 municípios levanta uma questão perturbadora: o remédio tomado para combater uma doença pode ter criado outra, mais resistente. Pesquisadores da Universidade Federal de Alagoas sugerem que o uso indiscriminado de ivermectina durante a pandemia de COVID-19 — um medicamento sem eficácia comprovada contra o vírus — pode ter gerado pressão seletiva sobre o ácaro da escabiose, tornando-o resistente ao próprio fármaco usado para eliminá-lo. O caso ainda aguarda confirmação, mas já aponta para uma verdade mais ampla: quando
NE10
· Nov 14, 2021
· health
· 3 min de leitura
Medium
Apuração: Caracterizado
UFAL study links ivermectin overuse to scabies outbreak in Pernambuco
Over 400 people across 12 municipalities affected by skin lesions causing itching and discomfort; outbreak concentrated in lower-income neighborhoods of Recife.
◉
Health & Medicine
2746 artigos relacionados
Ozempic and GLP-1 drugs: how the weight-loss revolution works and what…
O GLOBO · 99% correspondência
Anvisa aprova remdesivir contra covid-19 e registra vacina de Oxford
Jornal de Brasília · 90% correspondência
Brazil Gets New Blood Test for Early Alzheimer's Detection
Olhar Digital · 90% correspondência
Brazil's obesity guidelines shift focus from weight loss to disease ma…
Correio Braziliense · 90% correspondência
Eli Lilly's retatrutida shows 28% weight loss in trials, rivaling bari…
Poder360 · 90% correspondência
Cobertura Relacionada
G1 · Aug 20
Pai agradece médicos após morte de gêmeas unidas pela cabeça: 'mais vitórias que derrotas'
Pai das gêmeas unidas pela cabeça que morreram em cirurgia de separação agradece empenho de mais de 50 profissionais do …
Folha de S.Paulo · Aug 20 Selton Mello se emociona ao receber Kikito de Cristal em GramadoSelton Mello recebeu o Kikito de Cristal no Festival de Gramado e se emocionou ao lembrar que era a primeira vez receben…
G1 · Aug 20 CEMEI Amiguinhos da Vila inaugura prédio moderno com capacidade para 320 alunosInaugurado novo prédio do CEMEI Amiguinhos da Vila em Montes Claros, com capacidade para 320 alunos, oito salas de aula,…
Folha de S.Paulo · Aug 20 Hepatites D e E circulam no Brasil e preocupam especialistasRevisão de 200 estudos com dados de 14,5 milhões de pessoas revela que hepatites D e E circulam no Brasil com prevalênci…
Viés e Enquadramento
⚖
Article presents UFAL study linking ivermectin overuse to drug-resistant scabies outbreak with measured language, though framing emphasizes COVID-era misuse and public health concerns.
Bias Direction
center-left
Confidence
MED
Problem-solution framing combined with institutional authority framing. The article emphasizes the dangers of irrational medication use and positions the academic study as providing explanatory clarity for an unexplained outbreak. Framing highlights government/healthcare system failures in promoting ineffective COVID treatments.
uso indiscriminado (indiscriminate use)
abuso do remédio (drug abuse)
superresistência (super-resistance)
Comprovadamente ineficaz (provably ineffective)
uso irracional (irrational use)
problema de saúde pública (public health problem)
Perspective from healthcare providers who prescribed ivermectin during COVID-19
Defense or explanation from Ministry of Health regarding Kit Covid recommendations
Epidemiological data on scabies prevalence before and after COVID-19 period
Alternative hypotheses for the outbreak beyond ivermectin resistance
Voices from pharmaceutical industry or medical associations
Perspective from patients who used ivermectin
Impacto Geopolítico
🌎
Brazilian study links COVID-era ivermectin overuse to drug-resistant scabies outbreak in Pernambuco, raising public health concerns about antimicrobial resistance from irrational medication use.
Escalation Risk
low
Confidence
MED
Brazil
Pernambuco state
Recife
12 municipalities in Pernambuco
No direct geopolitical power shift. However, this reflects broader tensions between medical autonomy, public health governance, and pharmaceutical policy—highlighting how misinformation during COVID-19 (ivermectin promotion despite inefficacy) undermined institutional credibility in Brazil and created downstream health crises.
Similar to antibiotic resistance crises globally; reflects patterns of irrational drug use in developing regions with weaker pharmaceutical regulation, comparable to antimalarial resistance in sub-Saharan Africa.
Lente Econômica
📈
Indiscriminate ivermectin use during COVID-19 may have created drug-resistant scabies outbreak in Pernambuco, affecting 12 cities with 176 cases in Recife, signaling public health and pharmaceutical market risks.
Market Signal
bearish
Confidence
MED
Pharmaceutical/Drug Manufacturing
Healthcare Services
Public Health Administration
Dermatology Services
Medical Insurance/Health Plans
Consumers face increased healthcare costs for scabies treatment, potential treatment failures requiring alternative medications, and broader concerns about medication safety and efficacy. Public confidence in pharmaceutical guidance and health plans may decline.
Likely regulatory crackdown on off-label ivermectin promotion; stricter medication dispensing controls; mandatory pharmacovigilance protocols; potential liability for health plans and physicians who promoted ivermectin for COVID-19; increased scrutiny of antiparasitic drug distribution channels.